Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging

Investigative Radiology

Volumn 35, Issue 8, 2000, Pages 479-485

  Achilefu, Samuel ^a   Dorshow, Richard B ^a   Bugaj, Joseph E ^a   Rajagopalan, Raghavan ^a  

^a MALLINCKRODT PHARMACEUTICALS   (United States)

Author keywords

Contrast agents; Dye peptide conjugates; Optical imaging; Tumor targeting

Indexed keywords

CONTRAST MEDIUM; CYANINE DYE; CYPATE; CYTATE; FLUORESCENT DYE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAMERA; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; DIODE; DRUG EFFICACY; DRUG STRUCTURE; IMAGING SYSTEM; NONHUMAN; PRIORITY JOURNAL; RADIODIAGNOSIS; RAT; TISSUE DISTRIBUTION;

EID: 0033853378     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-200008000-00004     Document Type: Article

References (38)

1. Cancer statistics, 2000
2. Contrast media: Directions for the 1990s
3. Advances in tumor imaging
4. Optical time-of-flight and absorbance imaging of biologic media
5. In vivo endoscopic optical biopsy with optical coherence tomography
6. Noninvasive measurements of breast tissue optical properties using frequency-domain photon migration
7. Assessment of the size, position, and optical properties of breast tumors in vivo by noninvasive optical methods
8. Visualizing gene expression in living mammals using a bioluminescent reporter
9. Diagnostic imaging with light
10. Noninvasive fluorescence detection of hepatic and renal function
11. A novel method for fast imaging of brain function, non-invasively, with light
12. In vivo fluorescence spectroscopy and imaging for oncological applications
13. Early development of optical low-coherence reflectometry and some recent biomedical applications
14. Contrast media research
15. Fluorescence properties of rhodamine 800 in whole blood and plasma
16. Optical imaging of breast tumor by using dual wavelength amplitude cancellation system (phased array)
17. Receptor imaging: Competitive or complementary to antibody imaging?
18. Molecular biology of somatostatin receptors
19. Development of a tumor-targeting MR contrast agent using the high affinity folate receptor: Work in progress
20. The use of a thrombus-specific ultrasound contrast agent to detect thrombus in arteriovenous fistulae
21. Experimental tumor targeting with radiolabeled ligands
22. Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma
23. Tumor labeling in vivo using cyanine-conjugated monoclonal antibodies
24. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes
25. New contrast agents for optical imaging: Acid-cleavable conjugates of cyanine dyes with biomolecules
26. Barriers to drug delivery in solid tumors
27. Somatostatin receptor imaging in patients with sarcoidosis
28. 90Y-SMT 487) eradicates experimental rat pancreatic CA 20948 tumors
29. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function
30. Kinetics of indocyanine green removal from blood
31. Tumor localization using fluorescence of indocyanine green (ICG) in rat models
32. Receptor scintigraphy with a radioiodinated somatostatin analogue: Radiolabeling, purification, biological activity, and in vivo application in animals
33. 111Inlabeled somatostatin analogues for tumor scintigraphy and radionuclide therapy